Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001641172-25-014722
Filing Date
2025-06-11
Accepted
2025-06-11 16:31:38
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A formdefa14a.htm DEFA14A 13773
2 GRAPHIC proxy_001.jpg GRAPHIC 437971
3 GRAPHIC proxy_002.jpg GRAPHIC 407032
  Complete submission text file 0001641172-25-014722.txt   1179109
Mailing Address 505 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94111
Business Address 505 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94111 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

EIN.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40023 | Film No.: 251040479
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)